Recent Ebola outbreak highlights need for better global response

NIH scientist suggests immediate data sharing, regional diagnostic approach

2014-05-08

(Press-News.org) WHAT:
In an invited perspective article on the Ebola outbreak under way in West Africa, Heinz Feldmann, M.D., Ph.D., of the National Institutes of Health (NIH) emphasizes the need for scientists to make their data available to colleagues in real-time to improve the public health response to outbreaks. He cites past responses to influenza and SARS (severe acute respiratory syndrome) outbreaks as successful examples of global information sharing. Rapid diagnoses are key to controlling outbreaks of deadly viruses such as Ebola, for which no therapies are available. The immediate availability of viral gene sequencing data, for example, can reduce waiting times for test results and help to determine whether established test methods will work or fail.

Dr. Feldmann conducts research on Ebola and other hemorrhagic fever viruses at NIH's National Institute of Allergy and Infectious Diseases (NIAID). Among other suggestions, he recommends that medical and public health staff in and near locations known to be endemic for Ebola be trained to assess infection risks and diagnose disease. Enhancing the capabilities of local laboratory workers would make test results available more rapidly by eliminating the need to ship samples to distant reference laboratories.

Dr. Feldmann and his NIAID colleague David Safronetz, Ph.D., explored this regional diagnostic approach while working with Malian health researchers and officials in April, after the nation reported 12 suspected Ebola cases. The NIAID group worked at the International Center for Excellence in Research, a partnership between NIAID and Mali's University of Bamako, where they observed isolation procedures and showed local physicians how to handle Ebola specimens and test for disease. All of the suspected cases in Mali tested negative.

ARTICLE:
H. Feldmann. Ebola—A Surprise in West Africa? New England Journal of Medicine DOI: 10.1056/NEJMp1405314 (2014).

WHO:
NIAID Director Anthony S. Fauci, M.D., is available for interviews. Heinz Feldmann, M.D., Ph.D., an expert on Ebola virus and chief of NIAID's Laboratory of Virology, also is available.

INFORMATION: CONTACT:
To schedule interviews, please contact Ken Pekoc, (301) 402-1663, kpekoc@niaid.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIH...Turning Discovery Into Health® END

ELSE PRESS RELEASES FROM THIS DATE:

Malaria severity not determined solely by parasite levels in blood

2014-05-08

WHAT: Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild. Repeated infection does generate some immunity, and episodes of severe malaria are unusual once a child reaches age 5. However, the relative contributions of such factors as the level of malaria-causing parasites in a person's blood—parasite density—to disease severity and to development of protective immunity are not well understood. To clarify these issues, researchers from the United States and Tanzania regularly examined 882 ...

Berkeley Lab develops nanoscope to probe chemistry on the molecular scale

2014-05-08

For years, scientists have had an itch they couldn't scratch. Even with the best microscopes and spectrometers, it's been difficult to study and identify molecules at the so-called mesoscale, a region of matter that ranges from 10 to 1000 nanometers in size. Now, with the help of broadband infrared light from the Advanced Light Source (ALS) synchrotron at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), researchers have developed a broadband imaging technique that looks inside this realm with unprecedented sensitivity and range. By ...

Common drug may help treat effects of muscle disease in boys

2014-05-07

MINNEAPOLIS – A drug typically prescribed for erectile dysfunction or increased pressure in the arteries may help improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to a study published in the May 7, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology. Duchenne muscular dystrophy is a progressive and fatal muscle disease affecting boys and young men that causes loss of muscle function. There is no specific treatment for the disease, which is genetic. Corticosteroids can slow muscle degeneration ...

Multidimensional frailty score helps predict postoperative outcomes in older adults

2014-05-07

A multidimensional frailty score may help predict postoperative outcomes in older adults. More than half of all operations are performed on patients 65 years and older in the United States. Frail elderly patients who undergo surgery are more likely to have postoperative complications. But tools to estimate operative risk have their limitations because they often focus on a single organ system or solitary event. In geriatric medicine, the comprehensive geriatric assessment (CGA) is widely used to detect disabilities and conditions associated with frailty. The authors sought ...

Kaiser Permanente study finds radiation best treatment for a rare skin cancer

2014-05-07

OAKLAND, Calif. May 7, 2014 — Radiation treatment can help reduce the recurrence of Merkel cell carcinoma, a rare and aggressive skin cancer, while chemotherapy does not appear to have any impact on recurrence or survival, according to a Kaiser Permanente study published online in the current issue of JAMA Dermatology. The study presents one of the largest single-institution datasets on Merkel cell carcinoma, which occurs in about 1,500 people in the United States annually. Most such cancers occur on the sun-exposed skin of white males and are first diagnosed at age 75, ...

Official statement by ACS: Release of National Climate Assessment demands action

2014-05-07

WASHINGTON, May 7, 2014 — Yesterday's release of the third National Climate Assessment (NCA) should serve as a claxon call for policymakers and the general public to take action to address and mitigate the observable and documented adverse climate disruption impacts being observed in every region and key economic sector of the United States. These impacts, which have been observed and measured, are wreaking havoc with our society. This is a not a theoretical assessment; this report cites changes we are all observing and with which we are living. The future climate ...

A lab in your pocket

2014-05-07

When you get sick, your physician may take a sample of your blood, send it to the lab and wait for results. In the near future, however, doctors may be able to run those tests almost instantly on a piece of plastic about the size of credit card. These labs-on-a-chip would not only be quick—results are available in minutes—but also inexpensive and portable. They could be used miles from the nearest medical clinic to test for anything from HIV to diabetes. But as powerful as they may be, they could be far better, says Shiyan Hu, an associate professor of electrical and ...

Pushing the boundaries of stem cells

2014-05-07

(NEW YORK – May 7) Adults suffering from diseases such as leukemia, lymphoma, and other blood-related disorders may benefit from life-saving treatment commonly used in pediatric patients. Researchers at the Icahn School of Medicine at Mount Sinai have identified a new technique that causes cord blood (CB) stems cells to generate in greater numbers making them more useful in adult transplantation. The study, published in the May issue of The Journal of Clinical Investigation, looked at ways to expand the number of hematopoietic stem cells (HSC) in the laboratory required ...

NASA telescopes coordinate best-ever flare observations

2014-05-07

VIDEO: Watch the movie to see the wealth of colorful NASA observations of an X-class flare on March 29 -- the most comprehensively observed flare, ever. BROADCAST QUALITY: http://svs.gsfc.nasa.gov/vis/a010000/a011500/a011522/.... Click here for more information. On March 29, 2014, an X-class flare erupted from the right side of the sun... and vaulted into history as the best-observed flare of all time. The flare was witnessed by four different NASA spacecraft and one ground-based ...

Glutamate imaging better than MR spectroscopy in first 3 hours after ischemic stroke

2014-05-07

Leesburg, VA, May 5, 2014—Glutamate imaging reveals ischemic lesions in the first 3 hours after stroke that are not distinguishable in T1-weighted and T2-weighted imaging. Researchers using chemical exchange saturation transfer (CEST), an emerging MRI technology, have found that using glutamate with CEST shows high spatial resolution in vivo. The finding has the potential to speed diagnosis—and, therefore, treatment—in the critical first hours after a stroke. "I have been interested in glutamate imaging since its inception," said researcher Zhuozhi Dai of Second Affiliated ...

Recent Ebola outbreak highlights need for better global response

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: